Autism and epilepsy: Exploring the relationship using experimental models

Epilepsy Currents

Volumn 15, Issue 4, 2015, Pages 206-210

  Stafstrom, Carl E ^a   Benke, Tim A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BUMETANIDE; RAPAMYCIN;

ANTICONVULSANT THERAPY; ANXIETY; AUTISM; CHANNELOPATHY; COGNITION; COMPULSION; COPY NUMBER VARIATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABLED PERSON; DISEASE ASSOCIATION; DRUG EFFECT; ENVIRONMENTAL ENRICHMENT; ENVIRONMENTAL FACTOR; EPILEPSY; EXPERIMENTAL MODEL; FRAGILE X SYNDROME; GENE MUTATION; GENETIC MODEL; GLUTAMATERGIC SYNAPSE; HAMARTOMA; HUMAN; INTELLECTUAL IMPAIRMENT; INTERPERSONAL COMMUNICATION; LEARNING; LEARNING DISORDER; LOCOMOTION; MEMORY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; RETT SYNDROME; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOCIALIZATION; SPECIES DIFFERENCE; STEREOTYPY; TUBEROUS SCLEROSIS; ULTRASOUND; VOCALIZATION;

EID: 84942880136     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-15.4.206     Document Type: Review

References (67)

1. Small JG. EEG and neurophysiological studies of early infantile autism. Biol Psychiatr 1975;10:71-80.
2. Rossi PG, Parmeggiani A, Bach V, Santucci M, Visconti P. EEG features and epilepsy in patients with autism. Brain Dev 1995;17:169-174.
3. Tuchman R, Moshé SL, Rapin I. Convulsing toward the pathophysiology of autism. Brain Dev. 2009;31:95-103.
4. Brooks-Kayal A. Epilepsy and autism spectrum disorders: Are there common developmental mechanisms? Brain Dev 2010;32:731-738.
5. Berg AT, Plioplys S. Epilepsy and autism: Is there a special relationship? Epilepsy Behav 2012;23:193-198.
6. Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, Baulac M, Lechat P, Mottron L, Cohen D. Epilepsy in autism is associated with intellectual disability and gender: Evidence from a meta-analysis. Biol Psychiatr 2008;64:577-582.
7. Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams K. A systematic review of two outcomes in autism spectrum disorder-Epilepsy and mortality. Dev Med Child Neurol 2012;54:306-312.
8. Levy SE, Giarelli E, Lee LC, Schieve LA, Kirby RS, Cunniff C, Nicholas J, Reaven J, Rice CE. Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr 2010;31:267-275.
9. Schieve LA, Baio J, Rice CE, Durkin M, Kirby RS, Drews-Botsch C, Miller LA, Nicholas JS, Cunniff CM. Risk for cognitive deficit in a populationbased sample of U.S. children with autism spectrum disorders: Variation by perinatal health factors. Disabil Health J 2010;3:202-212.
10. Wallace KS, Rogers SJ. Intervening in infancy: Implications for autism spectrum disorders. J Child Psychol Psychiatry 2010;51:1300-1320.
11. Burke M. Report on special education finance, 2003. Education Commission of the States Web site. http://www.ecs.org/clearinghouse/48/92/4892.htm. Accessed June 11, Year.
12. Peacock G, Amendah D, Ouyang L, Grosse SD. Autism spectrum disorders and health care expenditures: The effects of co-occurring conditions. J Dev Behav Pediatr 2012;33:2-8.
13. Baio J; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years-Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014;63:1-21.
14. Buescher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 2014;168:721-728.
15. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism 2009;13:317-336.
16. Happé F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci 2006;9:1218-1220.
17. Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol 2014;10:74-81.
18. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013;493:327-337.
19. Santini E, Klann E. Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders. Sci Signal 2014;7:re10.
20. Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet 2013;14:191-213.
21. Belmonte MK, Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 2006;9:1221-1225.
22. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, Pierce K, Hagler D, Schork N, Lord C, Courchesne E. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci 2010;30:4419-4427.
23. Deonna T, Roulet E. Autistic spectrum disorder: Evaluating a possible contributing or causal role of epilepsy. Epilepsia 2006;47(suppl 2):79-82.
24. Stafstrom CE, Hagerman PJ, Pessah IN. Pathophysiology of epilepsy in autism spectrum disorders. In: Jasper's Basic Mechanisms of the Epilepsies. 4th ed. (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds.) Bethesda, MD: National Center for Biotechnology Information (US); 2012:900-914.
25. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatr 2007;16:61-66.
26. Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002;125:1247-1255.
27. Ebrahimi-Fakhari D, Sahin M. Autism and the synapse: Emerging mechanisms and mechanism-based therapies. Curr Opin Neurol 2015;28:91-102.
28. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943;2:217-250.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
30. London EB. Categorical diagnosis: A fatal flaw for autism research? Trends Neurosci 2014;37:683-686.
31. Wohr M, Schwarting RK. Ultrasonic communication in rats: Can playback of 50-kHz calls induce approach behavior? PLoS One 2007;2:e1365.
32. Wohr M, Schwarting RK. Ultrasonic communication in rats: Effects of morphine and naloxone on vocal and behavioral responses to playback of 50-kHz vocalizations. Pharmacol Biochem Behav 2009;94:285-295.
33. Crawley JN. Translational animal models of autism and neurodevelopmental disorders. Dialog Clin Neurosci 2012;14:293-305.
34. Stafstrom CE. Assessing the behavioral and cognitive effects of seizures on the developing brain. Prog Brain Res 2002;135:377-390.
35. Crawley JN. What's Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. Hoboken, NJ: Wiley-Interscience; 2007.
36. Stewart AM, Nguyen M, Wong K, Poudel MK, Kalueff AV. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatr 2014;50:27-36.
37. Gatto CL, Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2010;2:4.
38. Kang JQ, Barnes G. A common susceptibility factor of both autism and epilepsy: Functional deficiency of GABA A receptors. J Autism Dev Disord 2013;43:68-79.
39. Banerjee S, Riordan M, Bhat MA. Genetic aspects of autism spectrum disorders: Insights from animal models. Front Cell Neurosci 2014;8:58.
40. Curatolo P, Ben-Ari Y, Bozzi Y, Catania MV, D'Angelo E, Mapelli L, Oberman LM, Rosenmund C, Cherubini E. Synapses as therapeutic targets for autism spectrum disorders: An international symposium held in Pavia on July 4th, 2014. Front Cell Neurosci 2014;8:309.
41. Giovedí S, Corradi A, Fassio A, Benfenati F. Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: The case of synapsins. Front Pediatr 2014;2:94.
42. Bhakar AL, Dölen G, Bear MF. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 2012;35:417-443.
43. Berry-Kravis E. Mechanism-based treatments in neurodevelopmental disorders: Fragile X syndrome. Pediatr Neurol 2014;50:297-302.
44. Stafstrom CE. Neurobiological mechanisms of developmental epilepsy: Translating experimental findings into clinical application. Semin Pediatr Neurol 2007;14:164-172.
45. Bozzi Y, Casarosa S, Caleo M. Epilepsy as a neurodevelopmental disorder. Front Psychiatr 2012;3:19.
46. Holmes GL, Milh MD, Dulac O. Maturation of the human brain and epilepsy. Handb Clin Neurol 2014;107:135-143.
47. Buchmayer S, Johansson S, Johansson A, Hultman CM, Sparen P, Cnattingius S. Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics 2009;124:e817-e25.
48. Garfinkle J, Shevell MI. Prognostic factors and development of a scoring system for outcome of neonatal seizures in term infants. Eur J Paediatr Neurol 2011;15:222-229.
49. Glass HC, Hong KJ, Rogers EE, Jeremy RJ, Bonifacio SL, Sullivan JE, Barkovich AJ, Ferriero DM. Risk factors for epilepsy in children with neonatal encephalopathy. Pediatr Res 2011;70:535-540.
50. Abend NS, Wusthoff CJ. Neonatal seizures and status epilepticus. J Clin Neurophysiol 2012;29:441-448.
51. Lugo JN, Swann JW, Anderson AE. Early-life seizures result in deficits in social behavior and learning. Exp Neurol 2014;256:74-80.
52. Bernard PB, Benke TA. Early life seizures: Evidence for chronic deficits linked to autism and intellectual disability across species and models. Exp Neurol 2015;263:72-78.
53. Bernard PB, Castano AM, Beitzel CS, Carlson VB, Benke TA. Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype. Epilepsy Behav 2015;44:78-85.
54. Holmes GL, Tian C, Hernan AE, Flynn S, Camp D, Barry J. Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide. Neurobiol Dis 2015;77:204-215.
55. Talos DM, Sun H, Zhou X, Fitzgerald EC, Jackson MC, Klein PM, Lan VJ, Joseph A, Jensen FE. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLOS One 2012;7:e35885.
56. Lugo JN, Smith GD, Arbuckle EP, White J, Holley AJ, Floruta CM, Ahmed N, Gomez MC, Okonkwo O. Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. Front Mol Neurosci 2014;7:27.
57. Ruskin DN, Svedova J, Cote JL, Sandau U, Rho JM, Kawamura M Jr, Boison D, Masino SA. Ketogenic diet improves core symptoms of autism in BTBR mice. PLOS One 2013;8:e65021.
58. Waxman SG. Channel, neuronal, and clinical function in sodium channelopathies: From genotype to phenotype. Nat Neurosci 2007;10:405-409.
59. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: Emerging mechanisms. Nat Rev Neurol 2009;5:380-391.
60. Wasterlain CG, Gloss DS, Niquet J, Wasterlain AS. Epileptogenesis in the developing brain. Handb Clin Neurol 2013;3:427-439.
61. Staley K. Molecular mechanisms of epilepsy. Nat Neurosci 2015;18:367-372.
62. Volk L, Chiu SL, Sharma K, Huganir RL. Glutamate synapses in human cognitive disorders [published online ahead of print April 9, 2015]. Ann Rev Neurosci 2015.
63. Robinson S. Childhood epilepsy and autism spectrum disorders: Psychiatric problems, phenotypic expression, and anticonvulsants. Neuropsychol Rev 2012;22:271-279.
64. Chomiak T, Turner N, Hu B. What we have learned about autism spectrum disorder from valproic acid. Patholog Res Int 2013;2013:712758.
65. Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism-A current review of clinical and animal studies. Neurotoxicol Teratol 2013;36:47-56.
66. Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696-1703.
67. Simonato M, Brooks-Kayal AR, Engel J Jr, Galanopoulou AS, Jensen FE, Moshé SL, O'Brien TJ, Pitkanen A, Wilcox KS, French JA. The challenge and promise of anti-epileptic therapy development in animal models. Lancet Neurol 2014;13:949-960.